Bafna Pharmaceuticals
BAFNAPHNSE

Bafna Pharmaceuticals

₹110.74-0.58 (0.52%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
109.00
Today’s high
113.39
52 week low
70.61
52 week high
202.06
Open price
111.32
Previous close
111.32
Live volume
1,056
Lower circuit
105.76
Upper circuit
116.88

Fundamentals

Market Cap
₹263Cr
ROE
11.59%
P/E Ratio(TTM)
27.21
EPS(TTM)
4.08
P/B Ratio
2.88
Dividend Yield
0.00%
Industry P/E
38.82
Book Value
38.56
Debt to Equity
0.36
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Bafna Pharmaceuticals Limited manufactures pharmaceutical formulations, including betalactum and non-betalactum products, for domestic and export markets.;
MD/CEO
Bafna Mahaveer Chand
Founded in
1995
NSE symbol
BAFNAPH
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
75.00%
Retail And Others
15.66%
Foreign Institutions
9.34%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹699.50
-4.90 (0.70%)
L
    H
    4,025.7730.43.94
    ₹390.55
    +2.30 (0.59%)
    L
      H
      3,640.7240.624.99
      Aarti DrugsAARTIDRUGS
      ₹354.95
      +2.25 (0.64%)
      L
        H
        3,213.1615.872.19
        ₹290.20
        +1.60 (0.55%)
        L
          H
          2,905.6958.074.6
          2026
          11
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks